Hepatitis B Virus Panel, Chronic with Reflex to HBsAg Confirmation
Also known as: HEPCHRONIC
Use
This test is used to monitor patients with chronic hepatitis B infection who are known to have a positive Hepatitis B surface antigen (HBsAg). It helps determine the degree of infection and monitor the development of immunity. The test provides qualitative results for several hepatitis B virus markers, offering insights into the stage of infection and potential clinical outcomes.
Special Instructions
Not provided.
Limitations
This panel of assays is not suitable for blood donor screening or associated reentry protocols. It does not screen for human cells, tissues, and cellular- and tissue-based products (HCT/P). False positives can occur with HBsAg; therefore, clinical evidence should support results, and repeat testing may be necessary to clarify diagnosis. Results should be interpreted in conjunction with other clinical data to provide an accurate diagnosis.
FDA ApprovedNew York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 13953-5 - HBV e Ab SerPl Ql IA
- 13954-3 - HBV e Ag SerPl Ql IA
- 45159-1 - HBV & HDV Ab Ser-Imp
- 5193-8 - HBV surface Ab SerPl IA-aCnc
- 5196-1 - HBV surface Ag SerPl Ql IA
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3.5 mL
Minimum Volume
2.5 mL
Container
ARUP standard transport tube
Collection Instructions
Collect using a serum separator tube (SST). Separate serum from cells ASAP or within 2 hours of collection.
Patient Preparation
Refer to individual components.
Causes for Rejection
Heparinized plasma, specimens that are heat-inactivated, grossly hemolyzed, grossly icteric, grossly lipemic, or specimens containing particulate material.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 7 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant